Effect of Indocyanine Green-Guided Lymphadenectomy During Gastrectomy on Survival: Individual Patient Data Meta-Analysis
Cancers · 14.03.2025 · 17 (6) · 980
DOI: 10.3390/cancers17060980 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 14.03.2025. Verfasst von Matteo Calì und 11 weiteren Autor:innen. Beteiligte Einrichtung: I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio, Division of General Surgery, Department of Biomedical Science for Health, University of Milan, 20122 Mila…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Indocyanine green-guided (ICG-guided) lymphadenectomy during gastrectomy for cancer has been proposed to enhance the accuracy of lymphadenectomy. The impact of ICG-guided lymphadenectomy on patient survival remains debated.
Methods
The findings of the systematic review were reconstructed into an individual patient data (IDP) meta-analysis with restricted mean survival time difference (RMSTD). Overall survival (OS) and disease-free (DFS) survival were primary outcomes. RMSTD, standardized mead difference (SMD), and 95% confidence intervals (CI) were used as pooled effect size measures.
Results
Three studies (6325 patients) were included; 42% of patients underwent ICG-guided lymphadenectomy. The patients’ age ranged from 47 to 72 years and 58% were males. Proximal, distal, and total gastrectomy were completed in 6.8%, 80.4%, and 12.8% of patients, respectively. The surgical approach was laparoscopic (62.3%) and robotic (37.7%). ICG-guided lymphadenectomy was associated with a higher number of harvested lymph nodes compared to non-ICG-guided lymphadenectomy (SMD 0.50; 95% CI 0.45–0.55). At the 42-month follow-up, OS and DFS estimates for ICG-guided vs. non-ICG-guided lymphadenectomy were 0.5 months (95% CI −0.01, 1.1) and 1.3 months (95% CI 0.39, 2.15), respectively.
Conclusions
Our analysis suggests that ICG-guided lymphadenectomy offers equivalent long-term OS and DFS compared to non-ICG-guided lymphadenectomy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio, Division of General Surgery, Department of Biomedical Science for Health, University of Milan, 20122 Milan, Italy.
- Department of Surgery, Minimally Invasive UGI Surgery and Oncology, Yokohama City University Gastroenterological Center, Yokohama 232-0024, Japan.
- Minimally Invasive UGI Surgery, Severance Hospital-Division of General Surgery, Seoul 03722, Republic of Korea.
- Department of Oncologic Surgery 1-HPB, Division of General Surgery, Fondazione I.R.C.C.S Istituto Nazionale dei Tumori, 20133 Milan, Italy.
- Department of Obstetrics and Gynecology, IRCCS MultiMedica, 20138 Milan, Italy.
- G. Rodolico Hospital, Surgical Division, Department of General Surgery and Medical Surgical Specialties, University of Catania, 95131 Catania, Italy.
ORCID-Profile: Matteo Calì, Alberto Aiolfi, Sho Sato, Jawon Hwang, Francesca Albanesi, Antonio Biondi, Luigi Bonavina, Davide Bona
Zitieren
APA
Calì, M., Aiolfi, A., Sato, S., Hwang, J., Bonitta, G., Albanesi, F., Bonavina, G., Cavalli, M., Campanelli, G., Biondi, A., Bonavina, L., & Bona, D. (2025). Effect of Indocyanine Green-Guided Lymphadenectomy During Gastrectomy on Survival: Individual Patient Data Meta-Analysis. Cancers, 17(6), 980. https://doi.org/10.3390/cancers17060980
Vancouver
Calì M, Aiolfi A, Sato S, Hwang J, Bonitta G, Albanesi F, et al. Effect of Indocyanine Green-Guided Lymphadenectomy During Gastrectomy on Survival: Individual Patient Data Meta-Analysis. Cancers. 2025;17(6):980. doi:10.3390/cancers17060980
BibTeX
@article{Cal2025,
author = {Calì, Matteo and Aiolfi, Alberto and Sato, Sho and Hwang, Jawon and Bonitta, Gianluca and Albanesi, Francesca and Bonavina, Giulia and Cavalli, Marta and Campanelli, Giampiero and Biondi, Antonio and Bonavina, Luigi and Bona, Davide},
title = {Effect of Indocyanine Green-Guided Lymphadenectomy During Gastrectomy on Survival: Individual Patient Data Meta-Analysis},
journal = {Cancers},
year = {2025},
volume = {17},
number = {6},
pages = {980},
doi = {10.3390/cancers17060980}
}
EUVIMED